Overdoses and poisonings are sometimes familiar and sometimes frightening, and are a small but important part of the practice of emergency medicine. Toxicology will focus on the interesting world of poisons, their nature, effects and antidotes.
At the end of this program, the learner can expect to:
- By the end of this program, the learner will be able to:
- For apparently benign intoxication, not underestimate or miss the serious cases; and, not over treat the truly benign cases
- Use a systematic approach to a patient presenting with coma of unknown cause
- Look for physical signs that define and identify the toxidrome
- Use a systematic approach to treat an agitated/delirious patient to identify those with a toxic etiology
- Enhance elimination of toxins using appropriate methods
- Decontaminate the patient appropriately
- For a patient presenting with metabolic acidosis, come up with differential diagnosis and investigate to make a definite diagnosis
- Use antidotes appropriately
- Deal with the patient who refuses treatment while respecting their rights
- Use laboratory and other tests efficiently
- Look for and recognize difficult/serious intoxication that commonly kill, and manage them aggressively
- Modify your approach to pediatric intoxication by taking into account specific pediatric
|CFPC (with pre/post activity)||MAINPRO+||Up to 14 credits|
|RCPSC||Section 1||Up to 7 hours|
Dr. Margaret Thompson is the Medical Director of the Ontario, Manitoba and Nunavut Poison Centres, the President of the Canadian Association of Poison Control Centres and a practising Emergency Physician at St. Michael’s Hospital in Toronto. For the past 9 years, she has also been the Program Director for the Clinical Pharmacology & Toxicology Royal College Subspecialty Program at the University of Toronto and sat on the Royal College Subspecialty Committee. She is most proud of her current and graduated fellows, all of whom are now leaders in both Clinical Pharmacology and/or Toxicology in Canada. She is one of four course co-founders of the original 2003 CAEP Toxicology Roadshow, has presented a number of toxicology topics at continuing education venues, has been nominated for and won a number of teaching awards. She actively works with the Coroner’s Office, Public Health and Health Canada on toxicology surveillance, chemical emergency preparedness and evidence-based care of the poisoned patient.
Dr. Sophie Gosselin completed medical school at Université Laval (1997) and her residency in Emergency Medicine at McGill University (2002). During residency she completed a Certificate in Health Care Administration from Université de Montréal. She pursued a fellowship in medical toxicology with the Centre Antipoison du Québec, Newcastle Mater Misericordiae, Australia and in the UK (2003-2005). She has been working full-time as an emergency physician at McGill University Health Centre (2002) and as a toxicologist for the Centre Antipoison du Québec (2005).
She is the director of the MUHC adult emergency/clinical toxicology consultation service offering monthly electives to residents as well as assistant program director of the McGill Clinical Pharmacology and Toxicology program. She was awarded teacher of the year from McGill Emergency Medicine program in 2008 and from AMUQ in 2011. She enjoys organizing and was the scientific chair to CAEP 2010.
She has been invited to various conferences to talk on toxicology topics, discharge planning and medication safety issues. More recently, her research interests have focused on the evidence for extra-corporeal therapies in toxicology with the EXTRIP workgroup (co-chair) and acetaminophen poisoning with CAOS.
During her free time, between swimming and pilates, she grows edible flowers in her organic vegetable garden and watches as much sci-fi as she can.
Dr. Morgan Riggan completed her Bachelors of Science (BSc) at the University of British Columbia in 2007. She then moved to Ontario for her medical school training at McMaster University, finishing in 2010. Morgan completed her Royal College residency in emergency medicine at the University of Western Ontario in 2015. She is currently a second-year fellow in Medical Toxicology at New York University and living in New York City. She is also an attending physician at London Health Sciences Centre in London, Ontario, and an Adjunct Professor at UWO.
Dr. Marco Sivilotti is Professor and Deputy Head of Emergency Medicine at Queen’s University in Kingston, Ontario, Canada. He completed residency training in emergency medicine at McGill University in Canada, and fellowship training in medical toxicology at the University of Massachusetts in the United States. He has previously been on faculty at the University of Ottawa and Harvard Medical School, and is currently on staff at the Kingston General and Hotel Dieu Hospitals. He also serves as medical consultant to the Ontario Poison Centre in Toronto, and serves on the Royal College Specialty Committee for Clinical Pharmacology & Toxicology.
Late Registration Fee
(launched 6 weeks prior to course)
“The energy and enthusiasm of the instructors was fantastic. The common sense approach made it easy to learn.”
“This is the best CME course going. Should be required for all ED physicians”.
“The constant encouragement and non-intimidating approach of the instructors was good for learning. Keep up the great work! This course should be a pre-requisite for all residency programs.”
“This was an excellent course. I feel like I can approach AW decisions with some knowledge and CONFIDENCE. Thank you!”
CAEP’s CPD Challenge
Dialysis (acetaminophen is actually a very dialysable toxin and in massive overdoses causing mitochondrial paralysis, NAC is often not enough and we need to dialyze); Fomepizole (this is a CYP 2E1 inhibitor – which is the enzyme that metabolizes acetaminophen to it’s harmful metabolite, NAPQI. By inhibiting CYP 2E1, you inhibit the production of NAPQI); Doubling the 3rd phase of the NAC protocol (in massive ingestions – you often need more NAC!!!)
Anticholinergics, sympathomimetics, sepsis, meningitis/encephalitis, seretonin syndrome, neuroleptic malignant syndrome, malignant hyperthermia, heat stroke, ASA toxicity, withdrawal, thyrotoxicosis.